Colt Ventures: Funding, Team & Investors | Startup Intros

Loading organizations...

Colt Ventures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Apr 1, 2024	Alterome Therapeutics	$130.0M Series B	Josh Richardson	Andera Partners, Nextech Invest, OrbiMed, venBio, Vida Ventures, Boxer Capital, Uwe Schoenbeck, Digitalis Ventures, Driehaus Capital Management, Invus, Nextech Invest
Jan 1, 2024	BlossomHill Therapeutics	$100.0M Series B	Sundeep Agrawal	General Catalyst, OrbiMed, Sofinnova Investments, Bihua Chen, H&D Asset Management, Hercules BioVentures Partners, Plaisance Capital Management, Timothy Stubbs
Dec 1, 2023	Odyssey Therapeutics	$100.0M Series C	Lorence Kim	OrbiMed, SR One, Third Rock Ventures, AB Magnitude Ventures Group, Alexandria Venture Investments, BlackMars Capital, Catalio Capital Management, Creacion Ventures, CU Healthcare Innovation Fund, Fidelity Management & Research Company, Foresite Capital, General Catalyst, Global BioAccess Fund, HBM Healthcare Investments, KB Investment, Racing Beach Ventures, T. Rowe Price Associates, Walleye Capital, Woodline Partners
Nov 1, 2022	Alterome Therapeutics	$35.0M Series A	OrbiMed, Sundeep Agrawal	Andera Partners, Boxer Capital, Nextech Invest, Vida Ventures
Oct 1, 2022	Odyssey Therapeutics	$170.0M Series B	General Catalyst	Atlas Venture, EQT Life Sciences, f7 Ventures, Foresite Capital, OrbiMed, Pivotal bioVenture Partners, Soffinova Partners, SR One, Alexandria Venture Investments, Catalio Capital Management, Creacion Ventures, Fidelity Management & Research Company, GreatPoint Ventures, HBM Healthcare Investments, Leerink Partners, Logos Capital, T. Rowe Price Associates, Walleye Capital, Woodline Partners
Dec 1, 2021	Odyssey Therapeutics	$220.0M Series A	OrbiMed, SR One	Atlas Venture, EQT Life Sciences, Foresite Capital, Pivotal bioVenture Partners, Soffinova Partners, Creacion Ventures, HBM Healthcare Investments, Logos Capital, Woodline Partners
Oct 1, 2021	ReCode Therapeutics	$80.0M Series B	Oleg Nodelman	Bioluminescence Ventures, InterWest, MPM Capital, OrbiMed, Pfizer Venture Investments, Polaris Partners, Vida Ventures, Sam Altman, Hunt Technology Ventures, NS Investment, Osage University Partners, Sanofi Ventures, Superstring Capital, Tekla Capital Management
Apr 1, 2020	Erasca	$200.0M Series B	ARCH Venture Partners, Bihua Chen	Canaan Partners, SignalFire, City Hill Ventures, EDBI, Invus, LifeSci Venture Partners, Terra Magnum Capital Partners
Mar 1, 2020	ReCode Therapeutics	$80.0M Series A	OrbiMed, Colt Ventures	Bioluminescence Ventures, InterWest, MPM Capital, Pfizer Venture Investments, Vida Ventures, Sam Altman, Hunt Technology Ventures, Osage University Partners
Mar 1, 2020	Silverback Therapeutics	$79.0M Series B	U.S. Venture Partners	Andreessen Horowitz, Canaan Partners, Deerfield Management, Nextech Invest, Alexandria Venture Investments, Bristol Myers Squibb, Hunt Investment Group, Thilo Schroeder, NS Investment, OrbiMed, Pontifax
Apr 1, 2017	Bonti	$12.0M Series B	Alexey Konov	ARCH Venture Partners, SignalFire, City Hill Ventures, JMCR Partners
Jan 2, 2013	Ignyta	$5.5M Series B	City Hill Ventures	Silicon Valley Bank